Obesity and Lung Disease : A Guide to Pathophysiology, Evaluation, and Management (Respiratory Medicine) (2. Aufl. 2025. ix, 411 S. IX, 411 p. 41 illus., 30 illus. in color. 23)

個数:

Obesity and Lung Disease : A Guide to Pathophysiology, Evaluation, and Management (Respiratory Medicine) (2. Aufl. 2025. ix, 411 S. IX, 411 p. 41 illus., 30 illus. in color. 23)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版
  • 商品コード 9783031526985

Full Description

This new edition provides a fully updated guide to obesity's relation to lung disease. Over forty percent of the U.S. population is obese, and obesity is increasing in much of the world. Obesity has a major impact on health conditions such as diabetes and cardiovascular disease. The effects of obesity on lung disease have drawn increasing attention in recent years. Furthermore, the COVID pandemic has dramatically illustrated how obesity affects respiratory disease, constitutes a major risk factor for COVID-19, and presents challenges to pulmonary care in the ICU.

Obesity changes physiology, immune and metabolic function, and is associated with changes in diet and the microbiome, all of which combine to have a major impact on the pathogenesis of respiratory diseases. Obesity is thus a risk factor for many respiratory diseases such as asthma, pulmonary hypertension, thromboembolic disease, obstructive sleep apnea and ARDS. Obesity also complicates the management of manyother respiratory diseases and conditions such as COPD, thromboembolic disease, and the care of the critically ill patient.The objectives of this book are three-fold:

 To review how physiological, immune and metabolic factors might contribute to lung disease.
 To discuss the impact of obesity on common lung diseases
To outline important considerations in the management of critically ill obese patients.

There have been major advances in our understanding of the relationship between obesity and lung disease since the first edition in 2013, in addition to the major lessons learned about the importance of obesity during the COVID-19 pandemic. This has led to the addition of eight new chapters on topics such as, the microbiome, lung transplant, and COVID-19 in the ICU.

This is an ideal guide for all clinicians taking care of patients with pulmonary and critical care diseases, as well as basic and translational scientists interested in how obesity affects respiratory health.

Contents

SECTION I: Pathophysiology of Obesity and Lung Disease.- Airway Physiology and Lung Function.- Immune Function and Host Defense.- The Microbiome.- Metabolic Dysregulation.- Genetics and Genomics.- Diet and Nutrition.- SECTION II: Obesity and Respiratory Diseases.- Obstructive Sleep Apnea.- Obesity Hypoventilation Syndrome.- Asthma: Epidemiology and Clinical Presentation.- Asthma: Endotypes and Mechanisms.- Asthma: Management.- Chronic Obstructive Pulmonary Disease.- Pulmonary Hypertension.- Thromboembolic Disease.- Lung Transplant.- Respiratory Infections (Including COVID19).- Lung Health in Pediatrics.- SECTION III: Obesity and Critical Care.- ALI and ARDS.- Mechanical Ventilation.- COVID19 in the ICU

最近チェックした商品